SCIE期刊Current Molecular Pharmacology 2024/2025影响因子:2.425 (CURR MOL PHARMACOL) (1874-4672). (PHARMACOLOGY & PHARMACY)(药理

显示全部楼层 · 发表于 2025-3-25 04:14:46

Submitted on: 28 September 2004. Revised on: 02 December 2004. Accepted on: 16 December 2004. ___________________Current Molecular Pharmacology

显示全部楼层 · 发表于 2025-3-25 11:10:23

显示全部楼层 · 发表于 2025-3-25 11:47:44

显示全部楼层 · 发表于 2025-3-25 19:15:44

显示全部楼层 · 发表于 2025-3-25 21:54:10

Submitted on: 05 February 2013. Revised on: 16 May 2013. Accepted on: 20 June 2013. ___________________Current Molecular Pharmacology

显示全部楼层 · 发表于 2025-3-26 00:10:04

Submitted on: 29 November 2004. Revised on: 16 January 2005. Accepted on: 12 March 2005. ___________________Current Molecular Pharmacology

显示全部楼层 · 发表于 2025-3-26 06:43:25

Submitted on: 07 November 2002. Revised on: 01 January 2003. Accepted on: 04 February 2003. ___________________Current Molecular Pharmacology

显示全部楼层 · 发表于 2025-3-26 09:56:10

Submitted on: 30 July 2010. Revised on: 05 October 2010. Accepted on: 23 October 2010. ___________________Current Molecular Pharmacology

显示全部楼层 · 发表于 2025-3-26 13:09:12

显示全部楼层 · 发表于 2025-3-26 18:09:59

Submitted on: 26 August 2020. Revised on: 25 October 2020. Accepted on: 29 November 2020. ___________________Current Molecular Pharmacology

		自动登录	找回密码
密码			To register

关于派博传思			派博传思旗下网站			友情链接
派博传思介绍	公司地理位置	论文服务流程	影响因子官网	SITEMAP	大讲堂	北京大学	Oxford Uni.	Harvard Uni.
发展历史沿革	期刊点评	投稿经验总结	SCIENCEGARD	IMPACTFACTOR	派博系数	清华大学	Yale Uni.	Stanford Uni.
\|Archiver\|手机版\|小黑屋\| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-4-30 13:17
Copyright © 2001-2015 派博传思京公网安备110108008328 版权所有 All rights reserved